SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001104659-24-025223
Filing Date
2024-02-20
Accepted
2024-02-20 07:51:02
Documents
2
Group Members
ASTRAZENECA FINANCE & HOLDINGS INC.ISOCHRONE MERGER SUB INC.

Document Format Files

Seq Description Document Type Size
1 SC TO-T/A tm2332933d15_sctota.htm SC TO-T/A 39843
2 EXHIBIT 99.(A)(5)(H) tm2332933d15_ex99-a5h.htm EX-99.(A)(5)(H) 31459
  Complete submission text file 0001104659-24-025223.txt   73208
Mailing Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA
Business Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA 011 44 20 7304 5000
ASTRAZENECA PLC (Filed by) CIK: 0000901832 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC TO-T/A
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1930 BOREN AVE., SUITE 1000 SEATTLE WA 98101
Business Address 1930 BOREN AVE., SUITE 1000 SEATTLE WA 98101 (206) 737-0085
Icosavax, Inc. (Subject) CIK: 0001786255 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-92771 | Film No.: 24650766
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)